Laird A, Choy K C C, Delaney H, Cutress M L, O'Connor K M, Tolley D A, McNeill S A, Stewart G D, Riddick A C P
Edinburgh Urological Cancer Group, The University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU, UK,
World J Urol. 2015 Jan;33(1):25-32. doi: 10.1007/s00345-014-1280-y. Epub 2014 Mar 20.
The perioperative and oncological outcomes of laparoscopic radical nephrectomy (LRN) for T1-T2 renal cell carcinoma (RCC) are well established. We aim to determine whether LRN is a comparable alternative to open radical nephrectomy (ORN) in the treatment of T3 RCC using a matched pair analysis study design.
A review of a prospectively collected database at the Western General Hospital, Edinburgh, between 2000 and 2011 was conducted. Patient pairs were matched based on age at operation, gender, histological subgroup, maximal tumour diameter, TNM stage and grade. Patient demographics, operative and post-operative outcomes were compared. Overall, cancer-specific and progression-free survival [overall survival, cancer-specific survival (CSS) and progression-free survival (PFS)] were estimated using the Kaplan-Meier method.
From 252 patients with T3 disease, 25 pairs were matched. Patients were of median age 66.2 years, 64 % male. Tumours were all clear cell RCC, were stage pT3a (32 %) or pT3b and had maximal tumour diameters of 8.7 cm for LRN and 10.0 cm for ORN. Estimated blood loss (100 ml LRN; 650 ml ORN, p < 0.001) and length of post-operative hospital stay (4 days LRN: 9 days ORN, p < 0.001) were lower in the LRN group. Operation time and post-operative complication rates were comparable. CSS and PFS were comparable with a mean CSS of 91.3 months for LRN and 88.7 months for ORN.
This study reports the longest median follow-up in a T3 LRN cohort. In matched patients, LRN has been shown to have a superior perioperative profile to ORN for the treatment of pT3a/b RCC, with no adverse effect on midterm oncological outcomes.
腹腔镜根治性肾切除术(LRN)治疗T1 - T2期肾细胞癌(RCC)的围手术期和肿瘤学结局已得到充分证实。我们旨在通过配对分析研究设计,确定LRN在治疗T3期RCC时是否可作为开放性根治性肾切除术(ORN)的可比替代方案。
对爱丁堡西部总医院2000年至2011年期间前瞻性收集的数据库进行回顾。根据手术年龄、性别、组织学亚组、最大肿瘤直径、TNM分期和分级对患者进行配对。比较患者的人口统计学、手术和术后结局。总体而言,使用Kaplan - Meier方法估计总生存、癌症特异性生存(CSS)和无进展生存(PFS)。
从252例T3期疾病患者中,匹配出25对。患者的中位年龄为66.2岁,64%为男性。肿瘤均为透明细胞RCC,为pT3a期(32%)或pT3b期,LRN组的最大肿瘤直径为8.7 cm,ORN组为10.0 cm。LRN组的估计失血量(100 ml LRN;650 ml ORN,p < 0.001)和术后住院时间(4天LRN:9天ORN,p < 0.001)较低。手术时间和术后并发症发生率相当。CSS和PFS相当,LRN组的平均CSS为91.3个月,ORN组为88.7个月。
本研究报告了T3期LRN队列中最长的中位随访时间。在匹配患者中,LRN已被证明在治疗pT3a/b期RCC时围手术期表现优于ORN,且对中期肿瘤学结局无不良影响。